Corporate Update – Genfit SA (GNFT.PA)
Trading Performance (Wednesday 21st)
Genfit shares closed 8.3 % higher during the 24‑hour period ending at 02:26 PM Central Europe.
Current trading price is EUR 9.02 on major exchanges.
Shares traded in the last 24 hours amount to approximately EUR 2.6 million.
Market capitalization stands at EUR 417.3 million.
Outstanding share supply is 49.9 million.
Historical Price Levels
52‑week high: EUR 15.48 on 31 July 2026.
52‑week low: EUR 3.40 on 7 November 2025.
200‑day simple moving average: EUR 9.78.
Recent Trend
Since the end of last month, Genfit shares have declined by 17.13 %.
Related Stock Movements (Last 24 Hours)
| Symbol | Current Price | Change | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| CAT31.PA (Credit Agricole Toulouse) | EUR 99.99 | –0.61 % | EUR 448.8 million | 5.38 |
| FCMC.PA (Societe Fermiere Du Casino) | EUR 2,820 | –0.7 % | EUR 444.6 million | 17.93 |
| LBIRD.PA (Lumibird) | EUR 23.20 | +1.56 % | EUR 488.8 million | 37.03 |
| CMO.PA (Credit Agricole Du Morbihan) | EUR 91.44 | –3.16 % | EUR 498.5 million | 6.51 |
| LPE.PA (Laurent‑Perrier) | EUR 78.20 | +0.51 % | EUR 462.5 million | 8.85 |
Company Profile
Genfit SA is a biopharmaceutical firm focused on the development of therapeutic and diagnostic solutions for metabolic, inflammatory, autoimmune, and fibrotic diseases. Its research emphasis is primarily on liver and gastrointestinal conditions.
All figures are current as of the latest market close on 21 October 2026.